Futura Medical (FUM)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

9.29p
   
  • Change Today:
    -0.20p
  • 52 Week High: 40.00
  • 52 Week Low: 8.00
  • Currency: UK Pounds
  • Shares Issued: 303.83m
  • Volume: 249,253
  • Market Cap: £28.23m
  • RiskGrade: 479
  • Beta: 0.01

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth Not Available
1yr Revenue Growth
94.73% above the market average94.73% above the market average94.73% above the market average94.73% above the market average94.73% above the market average
86.21% above the sector average86.21% above the sector average86.21% above the sector average86.21% above the sector average86.21% above the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield Not Available
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
5.54% below the market average5.54% below the market average5.54% below the market average5.54% below the market average5.54% below the market average
36% below the sector average36% below the sector average36% below the sector average36% below the sector average36% below the sector average
Price Book Ratio
62.15% below the market average62.15% below the market average62.15% below the market average62.15% below the market average62.15% below the market average
21.05% below the sector average21.05% below the sector average21.05% below the sector average21.05% below the sector average21.05% below the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
29.29% above the market average29.29% above the market average29.29% above the market average29.29% above the market average29.29% above the market average
30.43% above the sector average30.43% above the sector average30.43% above the sector average30.43% above the sector average30.43% above the sector average
Price Chg 3m
89.17% below the market average89.17% below the market average89.17% below the market average89.17% below the market average89.17% below the market average
86.96% below the sector average86.96% below the sector average86.96% below the sector average86.96% below the sector average86.96% below the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
15.38% below the market average15.38% below the market average15.38% below the market average15.38% below the market average15.38% below the market average
19.05% above the sector average19.05% above the sector average19.05% above the sector average19.05% above the sector average19.05% above the sector average
Momentum 20
3.77% below the market average3.77% below the market average3.77% below the market average3.77% below the market average3.77% below the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
0.75% above the market average0.75% above the market average0.75% above the market average0.75% above the market average0.75% above the market average
48.39% above the sector average48.39% above the sector average48.39% above the sector average48.39% above the sector average48.39% above the sector average
ROCE Not Available

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
17.84% below the market average17.84% below the market average17.84% below the market average17.84% below the market average17.84% below the market average
51.11% above the sector average51.11% above the sector average51.11% above the sector average51.11% above the sector average51.11% above the sector average
Forecast EPS Not Available

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
35.17% below the market average35.17% below the market average35.17% below the market average35.17% below the market average35.17% below the market average
3.23% above the sector average3.23% above the sector average3.23% above the sector average3.23% above the sector average3.23% above the sector average
Operating Profit Loss
7.13% below the market average7.13% below the market average7.13% below the market average7.13% below the market average7.13% below the market average
55.56% above the sector average55.56% above the sector average55.56% above the sector average55.56% above the sector average55.56% above the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
33.13% below the market average33.13% below the market average33.13% below the market average33.13% below the market average33.13% below the market average
9.09% above the sector average9.09% above the sector average9.09% above the sector average9.09% above the sector average9.09% above the sector average
Cash
6.93% below the market average6.93% below the market average6.93% below the market average6.93% below the market average6.93% below the market average
13.64% above the sector average13.64% above the sector average13.64% above the sector average13.64% above the sector average13.64% above the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y
23.86% below the market average23.86% below the market average23.86% below the market average23.86% below the market average23.86% below the market average
66.67% below the sector average66.67% below the sector average66.67% below the sector average66.67% below the sector average66.67% below the sector average
Buys 1y
22.79% above the market average22.79% above the market average22.79% above the market average22.79% above the market average22.79% above the market average
3.45% below the sector average3.45% below the sector average3.45% below the sector average3.45% below the sector average3.45% below the sector average

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy
65.53% above the market average65.53% above the market average65.53% above the market average65.53% above the market average65.53% above the market average
62.50% above the sector average62.50% above the sector average62.50% above the sector average62.50% above the sector average62.50% above the sector average
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Futura Medical Market Data

Currency UK Pounds
Share Price 9.29p
Change Today -0.20p
% Change -2.11 %
52 Week High 40.00
52 Week Low 8.00
Volume 249,253
Shares Issued 303.83m
Market Cap £28.23m
Beta 0.01
RiskGrade 479

Futura Medical Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
40.08% below the market average40.08% below the market average40.08% below the market average40.08% below the market average40.08% below the market average
30.43% above the sector average30.43% above the sector average30.43% above the sector average30.43% above the sector average30.43% above the sector average
Price Trend
94.34% below the market average94.34% below the market average94.34% below the market average94.34% below the market average94.34% below the market average
95.65% below the sector average95.65% below the sector average95.65% below the sector average95.65% below the sector average95.65% below the sector average
Income Not Available
Growth
22.98% above the market average22.98% above the market average22.98% above the market average22.98% above the market average22.98% above the market average
20.00% above the sector average20.00% above the sector average20.00% above the sector average20.00% above the sector average20.00% above the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Futura Medical Dividends

No dividends found

Trades for 06-Jun-2025

Time Volume / Share Price
16:18 40,000 @ 9.43p
16:11 13 @ 9.58p
16:11 17 @ 9.58p
15:46 10,000 @ 9.39p
15:00 2,000 @ 9.15p

Futura Medical Key Personnel

CEO James Henry Barder
Finance Director Angela Hildreth

Top of Page